Identification of peptides and other organic substances to inhibit the virus-host cell-interaction
The new technology stands at an early stage of development (lab level). The inventors developed a method for identification of short coiled-coil sequences which are binding the viral envelope protein. The coiled-coil interaction is basic to the fusion of virus membrane with the target membrane. The identification of high specific, short peptides which can inhibit the virus-host cell interaction without induction of an immune response could lead to the development of new antiviral pharmaceuticals. The inventors developed a method of identification using SPOT-Technology on cellulose membranes. Investigation on HA2 virus (Influenza) and Tuberculosis are in process, studies on HIV, SIV, Ebola should follow.
Further Information: PDF
ipal GmbH
Phone: +49 (0)30/2125-4820
Contact
Ursula Haufe
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Microscopic basis of a new form of quantum magnetism
Not all magnets are the same. When we think of magnetism, we often think of magnets that stick to a refrigerator’s door. For these types of magnets, the electronic interactions…
An epigenome editing toolkit to dissect the mechanisms of gene regulation
A study from the Hackett group at EMBL Rome led to the development of a powerful epigenetic editing technology, which unlocks the ability to precisely program chromatin modifications. Understanding how…
NASA selects UF mission to better track the Earth’s water and ice
NASA has selected a team of University of Florida aerospace engineers to pursue a groundbreaking $12 million mission aimed at improving the way we track changes in Earth’s structures, such…
